INTERNATIONAL PATENT: WESTVAC BIOPHARMA CO., LTD., 成都威斯克生物医药有限公司 FILES APPLICATION FOR "RECOMBINANT PROTEIN VACCINE FOR PREVENTING AND TREATING SARS-COV-2 VARIANT JN.1, BA.2.86 AND XBB LINEAGES, COMBINATION DRUG AND USE"

Posted On: 2025-09-19

GENEVA, Sept. 19 -- WESTVAC BIOPHARMA CO., LTD. (No. 552 Fenghuang Road, Chengdu Tianfu International Bio-Town, Shuangliu DistrictChengdu, Sichuan 610000), 成都威斯克生物医药有限公司 (中国四川省成都市成都天府国际生物城（双流区凤凰路552号）) filed a patent application (PCT/CN2024/081625) for "RECOMBINANT PROTEIN VACCINE FOR PREVENTING AND TREATING SARS-COV-2 VARIANT JN.1, BA.2.86, AND XBB LINEAGES, COMBINATION DRUG AND USE" on Mar 14, 2024. With publication no. WO/2025/189415, the details related to the patent a...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: WESTVAC BIOPHARMA CO., LTD., 成都威斯克生物医药有限公司 FILES APPLICATION FOR "RECOMBINANT PROTEIN VACCINE FOR PREVENTING AND TREATING SARS-COV-2 VARIANT JN.1, BA.2.86 AND XBB LINEAGES, COMBINATION DRUG AND USE"